Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

被引：0
|
作者：
Fujita, K. [1 ]
机构：
[1] Natl Hosp Org Kyoto Med Ctr, Resp Med, Kyoto, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3918
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Incidence and Outcomes of MRI-confirmed Myocarditis in Patients Receiving Immune Checkpoint Inhibitors for Lung Cancer - A Single Tertiary Centre Experience
    So, Alfred
    Ghosh, Arjun K.
    Manisty, Charlotte
    Januszweski, Adam
    LUNG CANCER, 2024, 190
  • [22] Venous thromboembolism incidence and risk assessment in lung cancer patients treated with immune checkpoint inhibitors
    Icht, Oded
    Darzi, Naama
    Shimony, Shai
    Jacobi, Oded
    Reinhorn, Daniel
    Landman, Yosef
    Mutai, Raz
    Averbuch, Itamar
    Shochat, Tzippy
    Spectre, Galia
    Raanani, Pia
    Rotem, Ofer
    Dudnik, Elizabeth
    Peled, Nir
    Zer, Alona
    Leader, Avi
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (05) : 1250 - 1258
  • [23] Immune checkpoint inhibitors in lung cancer
    Koleczko, S.
    Wolf, J.
    INTERNIST, 2020, 61 (07): : 676 - 681
  • [24] AKI in Patients Receiving Immune Checkpoint Inhibitors
    Perazella, Mark A.
    Sprangers, Ben
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 1077 - 1079
  • [25] Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Keam, Bhumsuk
    Kang, Chang Kyung
    Jun, Kang Il
    Moon, Song Mi
    Suh, Koung Jin
    Lee, Dae-Won
    Ock, Chan-Young
    Kim, Miso
    Choi, Yunhee
    Lim, Yoojoo
    Lee, Kyung-Hun
    Kim, Se Hyun
    Kim, Tae Min
    Kim, Tae-Yong
    Oh, Youn
    Kim, Dong-Wan
    Im, Seock-Ah
    Lee, Jong Seok
    Kim, Eu Suk
    Kim, Hong Bin
    Kim, Nam-Joong
    Kim, Yu Jung
    Park, Wan Beom
    Oh, Myoung-don
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (02) : 422 - 425
  • [26] CAUSES OF HOSPITALIZATION AMONG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Choi, A.
    In, G.
    Brady, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A195 - A195
  • [27] Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Oren, Ohad
    Yang, Eric H.
    Molina, Julian R.
    Bailey, Kent R.
    Blumenthal, Roger S.
    Kopecky, Stephen L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (12): : 1920 - 1926
  • [28] Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors
    Yalciner, Merih
    Yazgan, Sati Coskun
    Mocan, Eda Eylemer
    Karaoglan, Beliz Bahar
    Bolek, Hatice
    Yekeduz, Emre
    Urun, Yuksel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [29] Clostridioides difficile infection in cancer patients receiving immune checkpoint inhibitors
    Vasavada, Shaleen
    Panneerselvam, Kavea
    Amin, Rajan
    Varatharajalu, Krishnavathana
    Okhuysen, Pablo C.
    Oliva, Isabella C. Glitza
    Wang, Jianbo
    Grivas, Petros
    Thomas, Anusha S.
    Wang, Yinghong
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (04): : 393 - +
  • [30] Cytomegalovirus infection among patients with cancer receiving immune checkpoint inhibitors
    Panneerselvam, Kavea
    Szafron, David
    Amin, Rajan N.
    Wei, Dongguang
    Tan, Dongfeng
    Altan, Mehmet
    Okhuysen, Pablo C.
    Shatila, Malek
    Raju, Gottumukkala Subba
    Thomas, Anusha S.
    Wang, Yinghong
    ANNALS OF GASTROENTEROLOGY, 2022, 35 (05): : 522 - +
12345